Bremer Bank National Association’s Gilead Sciences GILD Stock Holding History

Bremer Bank National Association’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,165	Closed	-$230K	–	228
2021 Q4	$230K	Buy	3,165 +33	+1%	+$2.27K	0.04%	205
2021 Q3	$219K	Sell	3,132 -126	-4%	-$8.85K	0.04%	190
2021 Q2	$224K	Buy	+3,258	New	+$218K	0.05%	191
2019 Q2	–	Sell	-2,555	Closed	-$166K	–	402
2019 Q1	$166K	Buy	+2,555	New	+$170K	0.03%	271

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bremer Bank National Association's GILD Position: Q1 2022 in Review

Bremer Bank National Association sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 3,165 shares — an estimated $230K sold.

Bremer Bank National Association first reported a position in GILD in Q1 2019 and held it in 4 quarters. The position peaked at $230K in Q4 2021. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Bremer Bank National Association reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Bremer Bank National Association sold 3,165 Gilead Sciences shares in Q1 2022, an estimated $230K.
Bremer Bank National Association first reported a position in Gilead Sciences in Q1 2019 and held it in 4 quarters.
Bremer Bank National Association's Gilead Sciences position peaked at $230K in Q4 2021.
1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Bremer Bank National Association's 13F filing for Q1 2022, filed 7 Apr 2022.